Clavis reports 50% remission in Phase II for acute myeloid lymphoma combo
18 August 2011
Pial Ganguli
Please Login to read the full article.
18 August 2011
Pial Ganguli
Please Login to read the full article.
RELATED CONTENT
NEWS
- Ben Venue manufacturing difficulties spell delays for Clavis' Phase III CLAVELA trial
- Clovis' $75M offering follows IPO, as pancreatic cancer candidate could carve out a niche
- ASCO 2012: Zytiga and Xalkori highlighted by at curtain raiser
- Astex dinged by US FDA verdict on failed Dacogen study
FEATURES
Other Informa Features
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
